Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Dosing for Attenuation of Maternal Pressor Response During Cesarean Section
DRKS00013556Phase 4Completed
- Sponsor
- Universitätsmedizin Essen
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in surgical stress (3 arms), sponsored by Universitätsmedizin Essen. Primary endpoints: Attenuation of maternal pressor response to endotracheal intubation and Attenuation of maternal pressor response to surgical incision. Started Dec 2017; status: completed.
02
Drugs
remifentanil
03
Conditions
surgical stress
Beyond the preview
Go deeper on DRKS00013556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00013556.